2019中国胃肠肿瘤圆桌会议纪要
收稿日期: 2020-01-14
网络出版日期: 2020-04-25
Gastrointestinal cancer in China 2019 meeting Summary
陆晟, 严超, 李琛, 张俊, 燕敏, 朱正纲 . 2019中国胃肠肿瘤圆桌会议纪要[J]. 外科理论与实践, 2020 , 25(02) : 178 -180 . DOI: 10.16139/j.1007-9610.2020.02.020
| [1] | Ji J, Liang H, Xue Y, et al. Peri/post-operative chemotherapy of oxaliplatin combined with S-1 (SOX) versus post-operative oxaliplatin with capecitabine (XELOX) in locally advanced gastric cancer: RESOLVE Trial[J]. J Clin Oncol, 2017, 35(15 Suppl):e15519. |
| [2] | Kodera Y, Yoshida K, Kochi M, et al. A randomized phase Ⅲ study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stageⅢ gastric cancer (JACCRO GC-07 trial)[J]. J Clini Oncol, 2018, 36(15 Suppl):4007. |
| [3] | Terashima M, Yoshida K, Rha SY, et al. International retrospective cohort study of conversion therapy for stage Ⅳ gastric cancer 1 (CONVO-GC-1)[J]. J Clin Oncol, 2018, 36(15 Suppl):4042. |
| [4] | Kang YK, Yook JH, Ryu MH, et al. A randomized phase Ⅲ study of neoadjuvant chemotherapy with docetaxel(D), oxaliplatin(O), and S-1(S) (DOS) followed by surgery and adjuvant S-1 vs. surgery and adjuvant S-1 for resectable advanced gastric cancer(PRODIGY)[J]. J Clin Oncol, 2015, 33(15 Suppl):TPS4136. |
| [5] | 严超, 燕敏, 朱正纲. 胃癌腹膜转移的转化治疗策略:新辅助腹腔内联合全身化疗[J]. 外科理论与实践, 2017, 22(1):28-31. |
/
| 〈 |
|
〉 |
